Trials / Completed
CompletedNCT00771342
Efficacy Study to Evaluate the Effect of Nitric Oxide on the Treatment of Tinea Pedis (Athlete's Foot)
A Blinded Placebo Controlled Single Cross-over Clinical Trial to Evaluate Fungicidal Activity With Topical Application of 1% Gaseous Nitric Oxide in Subjects With Moderate to Severe Tinea Pedis (Athlete's Foot)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Nitric BioTherapeutics, Inc · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the fungicidal efficacy of nitric oxide and it's effect on the clinical signs and symptoms associated with Tinea Pedis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitric Oxide | 1% gaseous nitric oxide, delivered for 40 minutes daily for 3 consecutive days |
| DRUG | Nitrogen | Nitrogen gas, delivered topically for 40 minutes daily for 3 consecutive days |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-06-01
- Completion
- 2009-08-01
- First posted
- 2008-10-13
- Last updated
- 2010-02-03
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00771342. Inclusion in this directory is not an endorsement.